Alnylam to webcast presentation at 40th annual j.p. morgan healthcare conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview at the 40th annual j.p. morgan healthcare conference, being held virtually, on monday, january 10, 2022 at 9:45 am et. this presentation will include an update on unaudited fourth quarter and full year 2021 global net product revenues. in addition, the company will webcast the q&a breakout session immediately
ALNY Ratings Summary
ALNY Quant Ranking